Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, novembre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
The Chemours Co
CC
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$12.09
-0.09
-0.74%
In chiusura: Nov 18, 4:00 PM EST
$12.18
N/A
Pre-mercato: 8:05 AM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Rapporto azionario
Dividendo:
La data di stacco del dividendo è stata 3 giorni fa
Chemours Financials
Chemours (CC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Chemours Narrows FY2026 Sales Guidance from $5.866B-$6.098B to $5.924B vs $5.917B Est
Chemours (NYSE:CC) narrows FY2026 sales outlook from $5.866 billion-$6.098 billion to $5.924 billion vs $5.917 billion estimate.
Benzinga Newsdesk
PRO
Chemours Sees Q4 Sales $1.671B-$1.750B vs $1.421B Est
Chemours (NYSE:CC) sees Q4 sales of $1.671 billion-$1.750 billion vs $1.421 billion analyst estimate.
Benzinga Newsdesk
PRO
Chemours Q3 Adj. EPS $0.21 Misses $0.27 Estimate, Sales $1.540B Inline
Chemours (NYSE:CC) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.27 by 22.22 percent. This is a 5 percent increase over earnings of $0.20 per share from the same period
Benzinga Newsdesk
PRO
Chemours Widens FY2026 Sales Guidance from $5.982B-$6.098B to $5.866B-$6.098B vs $6.044B Est
Chemours (NYSE:CC) widens FY2026 sales outlook from $5.982 billion-$6.098 billion to $5.866 billion-$6.098 billion vs $6.044 billion estimate.
Benzinga Newsdesk
PRO
Chemours Sees Q3 Sales $1.511B-$1.591B vs $1.601B Est
Chemours (NYSE:CC) sees Q3 sales of $1.511 billion-$1.591 billion vs $1.601 billion analyst estimate.
Benzinga Newsdesk
PRO
Chemours Q2 Adj. EPS $0.42, Inline, Sales $1.591B Miss $1.654B Estimate
Chemours (NYSE:CC) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is a 27.59 percent decrease over earnings of $0.58 per share from the same period last year. The company
Benzinga Newsdesk